Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-(2-oxo-1-pyrrolidinyl)phenyl)propanamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-(2-oxo-1-pyrrolidinyl)phenyl)propanamide
Unique ID
C500624
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C500624
Entry Term(s)
PHA 533533
PHA-533533
PHA533533
Registry Numbers
0
Heading Mapped to
*Pyrazoles
*Pyrrolidinones
Frequency
2
Note
a CDK2 inhibitor with antineoplastic activity; structure in first source
Source
J Med Chem 2005 Apr 21;48(8):2944-56
Indexing Information
Cyclin A
Date of Entry
2005/05/22
Revision Date
2005/05/22
N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(4-(2-oxo-1-pyrrolidinyl)phenyl)propanamide Preferred
PHA 533533 Narrower
page delivered in 0.004s